2015-08-12T16:08:01-05:00 2014-09-30 ERNST & YOUNG US LLP 18111 VON KARMAN AVENUE SUITE 1000 IRVINE CA 92612 990 2013-10-01 953432210 Beckman Research Institute of the City of Hope % RICHARD MAGNUSON/CITY OF HOP BECK 6269305445 1450 East Duarte Road Suite Duarte CA 91010 RICHARD MAGNUSON CHIEF FINANCIAL OFFICER 6263018156 2015-08-10 true KARA ADAMS P00023315 6263018156 2013 2016-02-25 16:41:14Z ROBERT STONE 1500 EAST DUARTE ROAD DUARTE CA 91010 432461177 false X www.cityofhope.org X 1979 CA QUICKLY BRING RESEARCH IDEAS TO TREATMENT FOR CURES TO PATIENTS WHO NEED THEM. MEDICAL & BIOMEDICAL RESEARCH & DISEASE INVESTIGATION, INCLUDING DNA SYNTHESIS AND CELL ANALYSIS. 7 5 901 5 -1268670 269053240 247879165 5008244 3828641 25522949 46639302 1312455 591610 300896888 298938718 0 0 0 0 103278861 104459913 0 0 2395250 158370056 160814495 261648917 265274408 39247971 33664310 930429780 1002567058 138907153 145246924 791522627 857320134 X SEE SCHEDULE O false false 232359306 0 5688921 BIOMEDICAL RESEARCH AND DISEASE INVESTIGATIONS, INCLUDING DNA SYNTHESIS AND CELL ANALYSIS. SEE SCHEDULE O. 232359306 true true false true false false false false false true true true false false true true false true false false true false false false false false false false false true true false false false false false true false false true false false false false false false true true true false false true 393 0 true 901 true true true true BD VI CJ false false false false false false false false X 7 5 false false true false true true true true true false false false true true true true true true true false CA X RICHARD MAGNUSONCITY OF HOP 6263018156 1500 EAST DUARTE ROAD DUARTE CA 91010 X GARY E FREEDMAN BOARD MEMBER 3.0 0.0 X 0 0 0 IRIS ROTHSTEIN BOARD MEMBER 3.0 2.0 X 0 0 0 JOHN J ROSSI Board Member/Research Sci 60.0 0.0 X 285222 0 61690 BENHAM BADIE MD BOARD MEMBER 3.0 0.0 X 0 0 0 ART NEMIROFF BOARD MEMBER 3.0 0.0 X 0 0 0 LINDA MALKAS BOARD MEMBER 60.0 0.0 X 443233 0 49238 ERNIE SO BOARD CHAIR 3.0 2.0 X 0 0 0 GREGORY SCHETINA GENERAL COUNSEL/SECRETARY 15.0 45.0 X 142808 428421 95349 MICHAEL A FRIEDMAN MD CEO - OUTGOING 6.0 54.0 X 152106 1368948 124948 ROBERT W STONE PRESIDENT AND CEO 15.0 45.0 X 287475 862421 160357 WILLIAM SARGEANT ASSISTANT SECRETARY/COO 15.0 45.0 X 209149 627441 139173 RICHARD MAGNUSON TREASURER/CFO 15.0 45.0 X 208643 625929 110526 WAEL FAKHRY ASSISTANT TREASURER/SVP FINOPS 13.0 47.0 X 85867 321086 61575 DAVID HORNE CHAIRPERSON/PROFESSOR 60.0 0.0 X 639883 0 46915 LARRY A COUTURE SVP CATD 60.0 0.0 X 432696 0 40678 ASHLEY BAKER LEE SVP, RESEARCH OPERATIONS 60.0 0.0 X 445291 0 58617 DEBRA FIELDS CHIEF RISK OFFICER 15.0 45.0 X 142937 428809 97671 PAUL CONOCENTI SVP AND CIO 15.0 45.0 X 166900 500695 69952 STEPHANIE NEUVIRTH CHIEF HR OFFICER 15.0 45.0 X 172354 517059 129820 GERD PFEIFER CHAIRPERSON/PROFESSOR 60.0 0.0 X 309306 0 55391 HUA YU JOVE PROFESSOR 60.0 0.0 X 448045 0 48765 LESLIE BERNSTEIN DEAN OF FACULTY AFFAIRS 60.0 0.0 X 354385 0 51696 RAMA NATARAJAN CHAIRPERSON/PROFESSOR 60.0 0.0 X 292752 0 50421 RICHARD THOMPSON VP, FACILITIES 15.0 45.0 X 95786 287355 29679 RICHARD JOVE FORMER OFFICER 0.0 0.0 X 258664 0 42551 VALERIE BINGHAM FORMER OFFICER,VP/CONTROLLER 15.0 45.0 X 71108 213323 44963 5644610 6181487 1569975 146 true true false CONTROL AIR CONDITIONING CORPORATIO 5200 EAST LA PALMA AVE ANAHEIM CA 92807 REPAIRS/MAINTENANCE 3365898 HURON CONSULTING SERVICES LLC PO BOX 71223 CHICAGO IL 60694 CONSULTING SERVICES 1039925 UNIVERSITY OF SOUTHERN CALIFORNIA FILE NO 52095 LOS ANGELES CA 90074 Research Services 1791957 CANCER PREVENTION INSTITUTE 2201 WALNUT AVENUE SUITE 300 FREMONT CA 94538 RESEARCH SERVICES 726853 UNIVERSITY OF CALIFORNIA IRVINE ACCOUNTING OFFICE SUITE 1400 IRVINE CA 92697 RESEARCH SERVICES 668278 38 184727119 58427236 4724810 247879165 OTHER RESEARCH ACTIVITIES 541900 3004944 3004944 ACADEMIC STAFF REVENUE 541900 159491 159491 SPECIALIZED LAB REVENUE 541900 541388 541388 RENTAL INCOME - PROGRAM SERVICE 541900 122818 122818 3828641 15663759 15663759 871 871 1854352 1854352 0 0 0 164497131 133522459 30974672 30974672 30974672 0 0 0 INVESTMENT INCOME FROM K-1'S 525990 -1268670 -1268670 MISCELLANEOUS REVENUE 900099 5928 5928 -1262742 298938718 5688921 -1268670 46639302 0 0 0 0 4848043 1415804 3261149 171090 86081 86081 80458740 69606554 9911583 940603 5216532 4546404 520199 149929 8740520 7581510 908629 250381 5109997 4233380 802949 73668 0 3690746 3405346 285400 247265 247265 0 0 1617300 1617300 17412438 11560382 5071114 780942 81704 81704 25718506 23946720 1768108 3678 2533299 867150 1665962 187 0 6548153 5314077 1226536 7540 1309545 1124882 184651 12 0 331900 199741 132159 4620044 4160056 459988 0 15972881 15355310 601292 16279 571983 547823 23289 871 ROYALTY REVENUE SHARING 76987020 76987020 DUES AND SUBSCRIPTIONS 1660646 793749 866897 TAXES AND LICENSES 325289 325289 OTHER MISCELLANEOUS 1185776 713398 472308 70 265274408 232359306 30519852 2395250 291037 13316715 70402215 3555212 6968441 10896333 0 0 472762 460610 0 0 1599949 1601765 242812 194 442520 7052 358590765 128834993 229613032 229755772 250093936 305412199 367963275 436031488 0 0 0 0 2339801 1529718 930429780 1002567058 17449194 22169904 0 0 8667436 5660409 55054287 55054287 0 0 0 0 50000000 50000000 0 0 7736236 12362324 138907153 145246924 X 774549396 838791089 3231332 4766594 13741899 13762451 791522627 857320134 930429780 1002567058 X 33664310 34183693 -2050496 X X false true X true true true X CITY OF HOPE NATIONAL MEDICAL CENTER DUARTE CA false false false RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED X 1027111 1027111 265274408 1393404224 265274408 1394431335 1000000 1000000 250000 250000 27111 false 1000000 1000000 1000000 1000000 4000000 6000000 547607 498406 387460 1027111 2460584 250000 250000 250000 250000 1000000 1500000 0 0 15000 0 15000 LOBBYING ADDITIONAL DISCLOSURES: SCHEDULE C, PART II-A, Line A ALTHOUGH THIS QUESTION WAS ANSWERED "YES", BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE (BECKMAN RESEARCH INSTITUTE) HAS NOT MADE THE 501(H) ELECTION AND DOES NOT HAVE ANY DIRECT LOBBYING EXPENDITURES IN FISCAL YEAR 2014. BECKMAN RESEARCH INSTITUTE BELONGS TO AN AFFILIATED GROUP, WHERE THE CITY OF HOPE NATIONAL MEDICAL CENTER (MEDICAL CENTER) APPLIED FOR A SECTION 501(H) ELECTION ON FORM 5768 IN THE YEAR ENDED SEPTEMBER 30, 1995. DURING FISCAL YEAR 2014 CITY OF HOPE NATIONAL MEDICAL CENTER FILED FORM 5768 TO REVOKE THE ELECTION UNDER THE PROVISIONS OF SECTION 501(H) OF THE CODE RELATING TO EXPENDITURES TO INFLUENCE LEGISLATION. THIS IS EFFECTIVE OCTOBER 1, 2014 FOR THE FISCAL YEAR 2015. THE FOLLOWING ARE THE OTHER MEMBERS OF THE AFFILIATED GROUP: CITY OF HOPE (HAS NOT MADE THE 501(H) ELECTION) 1500 EAST DUARTE ROAD, DUARTE, CA 91010 EIN = 95-3435919 GRASSROOTS LOBBYING AMOUNT = NONE TOTAL LOBBYING EXPENDITURES = NONE OTHER EXEMPT PURPOSE EXPENDITURES = $262,333,692 TOTAL EXEMPT PURPOSE EXPENDITURES = $262,333,692 LOBBYING NONTAXABLE AMOUNT = NONE GRASSROOTS NONTAXABLE AMOUNT = NONE TOTAL GRASSROOTS LESS NONTAXABLE AMOUNT = NONE TOTAL EXPENDITURES LESS NONTAXABLE AMOUNT = NONE SHARE OF EXCESS LOBBYING EXPENDITURES = NONE MEDICAL CENTER (HAS MADE THE 501(H) ELECTION) 1500 EAST DUARTE ROAD, DUARTE, CA 91010 EIN = 95-1683875 GRASSROOTS LOBBYING AMOUNT = NONE TOTAL LOBBYING EXPENDITURES = $1,027,111 OTHER EXEMPT PURPOSE EXPENDITURES = $721,925,308 TOTAL EXEMPT PURPOSE EXPENDITURES = $722,952,419 LOBBYING NONTAXABLE AMOUNT = NONE GRASSROOTS NONTAXABLE AMOUNT = NONE TOTAL GRASSROOTS LESS NONTAXABLE AMOUNT = NONE TOTAL EXPENDITURES LESS NONTAXABLE AMOUNT = NONE SHARE OF EXCESS LOBBYING EXPENDITURES = NONE CITY OF HOPE MEDICAL FOUNDATION (MEDICAL FOUNDATION) (HAS NOT MADE THE 501(H) ELECTION) 1500 EAST DUARTE ROAD, DUARTE, CA 91010 EIN = 27-4803222 GRASSROOTS LOBBYING AMOUNT = NONE TOTAL LOBBYING EXPENDITURES = NONE OTHER EXEMPT PURPOSE EXPENDITURES = $143,870,816 TOTAL EXEMPT PURPOSE EXPENDITURES = $143,870,816 LOBBYING NONTAXABLE AMOUNT = NONE GRASSROOTS NONTAXABLE AMOUNT = NONE TOTAL GRASSROOTS LESS NONTAXABLE AMOUNT = NONE TOTAL EXPENDITURES LESS NONTAXABLE AMOUNT = NONE SHARE OF EXCESS LOBBYING EXPENDITURES = NONE 514729850 20552 61593960 0 65050 0 576279312 455249503 20000 59716262 0 255945 0 514729820 393755522 25000 61930306 0 461325 0 455249503 405464661 0 -11243318 0 465791 0 393755552 377557199 50000 28270983 0 413521 0 405464661 0.96785 0.02388 0.00827 false false 2592400 7700887 10293287 238354970 68651719 169703251 8572 8572 0 96628838 60174702 36454136 13305098 13305098 229755772 ALTERNATIVE INVESTMENTS 436031488 F 436031488 0 DUE TO AFFILIATES 4926324 INTEREST RATE SWAP LIABILITY 3363262 WORKERS COMPENSATION LIABILITY 1291134 OTHER LIABILITIES 227830 BOND ISSUANCE PREMIUM 2553774 12362324 X ENDOWMENT FUNDS SCHEDULE D, PART V, LINE 4 BECKMAN RESEARCH INSTITUTE HAS BOARD DESIGNATED ASSETS AND QUASI-ENDOWMENT FUNDS THAT ARE AVAILABLE TO FUND FUTURE RESEARCH, AND CAPITAL AND EXPANSION NEEDS AS DETERMINED BY THE MANAGEMENT AND THE BOARD OF DIRECTORS. FASB ASC 740 DISCLOSURE: SCHEDULE D, PART X, LINE 2 THE FOLLOWING PARAGRAPH IS FROM THE CONSOLIDATED CITY OF HOPE AND AFFILIATES (CITY OF HOPE, CITY OF HOPE AUXILIARIES, CITY OF HOPE NATIONAL MEDICAL CENTER, CITY OF HOPE MEDICAL FOUNDATION AND THE BECKMAN RESEARCH INSTITUTE OF THE CITY OF HOPE) AUDITED FINANCIAL STATEMENTS AS OF SEPTEMBER 30, 2014. FINANCIAL ACCOUNTING STANDARDS BOARD (FASB), ACCOUNTING STANDARDS CODIFICATION ASC 740, INCOME TAXES, CLARIFIES THE ACCOUNTING FOR INCOME TAXES BY PRESCRIBING A MINIMUM RECOGNITION THRESHOLD THAT A TAX POSITION IS REQUIRED TO MEET BEFORE BEING RECOGNIZED IN THE FINANCIAL STATEMENTS. FASB ASC 740 ALSO PROVIDES GUIDANCE ON DERECOGNITION, MEASUREMENT, CLASSIFICATION, INTEREST AND PENALTIES, DISCLOSURE AND TRANSITION. THE GUIDANCE CONTAINED IN FASB ASC 740 IS APPLICABLE TO PASS-THROUGH ENTITIES AND TAX-EXEMPT ORGANIZATIONS. CITY OF HOPE HAS NO SIGNIFICANT UNCERTAIN TAX POSITIONS OR TAX LIABILITIES FOR TAX BENEFITS, INTEREST OR PENALTIES ACCRUED AT SEPTEMBER 30, 2014 AND 2013. Central America and the Caribbean Investments 124202946 Central America and the Caribbean 1 Program Services RESEARCH SYMPOSIUMS 1247 East Asia and the Pacific 16 Program Services RESEARCH SYMPOSIUMS 51793 Europe (Including Iceland and Greenland) 34 Program Services RESEARCH SYMPOSIUMS 86976 Middle East and North Africa 1 Program Services RESEARCH SYMPOSIUMS 1082 North America 28 Program Services RESEARCH SYMPOSIUMS 51590 Russia and the Newly Independent States 4 Program Services RESEARCH SYMPOSIUMS 5363 Sub-Saharan Africa 1 Program Services RESEARCH SYMPOSIUMS 1462 78 85 124402459 124402459 true false true true true false ACTIVITIES PER REGION: SCHEDULE F, PART I, LINE 3 INVESTMENT ACTIVITIES OF THE BECKMAN RESEARCH INSTITUTE INCLUDE INVESTMENTS IN MULTIPLE VEHICLES THAT PROVIDE INVESTMENT INCOME AND RETURNS TO THE INSTITUTION TO FURTHER ITS MISSION AND PROGRAMS. AS A RESULT, THERE ARE INVESTMENTS HELD IN OFFSHORE HEDGE FUNDS, MAINLY REGISTERED AS CAYMAN EXEMPTED CORPORATIONS. THESE INVESTMENTS HELP MITIGATE RISK IN THE PORTFOLIO AND REPRESENT APPROXIMATELY 16.4% OF BECKMAN RESEARCH INSTITUTE'S OVERALL CASH AND INVESTMENT PORTFOLIO. THE BECKMAN RESEARCH INSTITUTE HAS HOLDINGS THAT INCLUDE EQUITY AND FIXED INCOME CO-MINGLED FUNDS THAT INVEST PRIMARILY IN MARKETABLE EQUITY SECURITIES. THESE FUNDS ARE SUBJECT TO CERTAIN NOTICE REQUIREMENTS, BUT CAN BE LIQUIDATED AT LEAST MONTHLY. ALTERNATIVE INVESTMENTS ALSO INCLUDE HEDGE FUNDS AND LIMITED PARTNERSHIP FUNDS INVESTED IN REAL ESTATE AND NATURAL RESOURCES, MASTER LIMITED PARTNERSHIPS, PRIVATE EQUITY FUNDS, AND OFFSHORE FUNDS. ALL OF THESE INVESTMENTS HAVE BEEN INCLUDED IN FORM 990, PART X, LINE 12. RESEARCH SYMPOSIA CONSIST OF SCIENTIFIC MEETINGS THAT BECKMAN RESEARCH INSTITUTE PRINCIPAL INVESTIGATORS AND OTHER RESEARCH STAFF ATTEND FOR EDUCATIONAL, RESEARCH AND SCIENTIFIC PURPOSES AND TO PRESENT AND SHARE RESEARCH OBJECTIVES AND RESULTS. RESEARCH HAS A GLOBAL REACH AND RESEARCH SYMPOSIA ARE OFTEN CONDUCTED IN THE VARIOUS REGIONS IDENTIFIED IN SCHEDULE F. CITY OF HOPE SUPPORTS ATTENDANCE OF OUR RESEARCH STAFF AT THESE SYMPOSIA. EMPLOYEE TRAVELERS MAY MAKE MULTIPLE TRIPS TO THE SAME REGION OR TO MULTIPLE REGIONS DURING A FISCAL YEAR. IN THE CASE WHERE THE SAME EMPLOYEE TRAVELER MADE MORE THAN ONE TRIP TO THE SAME REGION, THEY ARE ONLY COUNTED ONE TIME AS A TRAVELER TO THAT REGION. IF THE SAME EMPLOYEE TRAVELER TRAVELS TO MORE THAN ONE REGION, THAT INDIVIDUAL IS COUNTED ONLY ONCE IN EACH REGION VISITED. THE TOTAL TRAVELERS ON LINE 3A, HOWEVER, ONLY COUNTS THE SAME TRAVELER ONCE IN THE GRAND TOTAL. AS A RESULT THE TOTAL TRAVELERS PER REGION WILL NOT ADD UP TO THE TOTAL ON LINE 3A. WE HAD 7 INSTANCES IN WHICH THE SAME TRAVELER TRAVELED TO MULTIPLE REGIONS DURING THE FISCAL YEAR ENDING SEPTEMBER 30, 2014. THE BECKMAN RESEARCH INSTITUTE DOES NOT HAVE ANY PHYSICAL PRESENCE OR EMPLOYEES OUTSIDE OF THE UNITED STATES. THE BECKMAN RESEARCH INSTITUTE'S REPUTATION AS A WORLD CLASS RESEARCH AND TREATMENT FACILITY IS INTERNATIONALLY RECOGNIZED. AS A RESULT OF THIS RECOGNITION, THE BECKMAN RESEARCH INSTITUTE RECEIVES DONATIONS AND GRANTS FROM PERSONS AND CORPORATIONS OUTSIDE OF THE UNITED STATES. SCHEDULE F, PART I, COLUMN F THE EXPENDITURES IN COLUMN F ARE DETERMINED USING THE ACCRUAL METHOD OF ACCOUNTING. INTERNATIONALLY RECOGNIZED. AS A RESULT OF THIS RECOGNITION, THE BECKMAN RESEARCH INSTITUTE RECEIVES DONATIONS AND GRANTS FROM PERSONS AND CORPORATIONS OUTSIDE OF THE UNITED STATES. SCHEDULE F, PART I, COLUMN F THE EXPENDITURES IN COLUMN F ARE DETERMINED USING THE ACCRUAL METHOD OF ACCOUNTING. X false false false true false false false false false true false JOHN J ROSSI Board Member/Research Sci 256588 0 24611 0 4023 0 38250 0 23440 0 346912 0 0 0 LINDA MALKAS BOARD MEMBER 353457 0 6009 0 83767 0 38250 0 10988 0 492471 0 0 0 GREGORY SCHETINA GENERAL COUNSEL/SECRETARY 88000 264001 49452 148354 5356 16066 16390 49169 7448 22342 166646 499932 0 0 MICHAEL A FRIEDMAN MD CEO - OUTGOING 78826 709429 52934 476401 20346 183118 9787 88080 2708 24373 164601 1481401 0 0 ROBERT W STONE PRESIDENT AND CEO 157844 473531 106491 319472 23140 69418 32005 96014 8085 24253 327565 982688 0 0 WILLIAM SARGEANT ASSISTANT SECRETARY/COO 130083 390247 77720 233158 1346 4036 29013 87037 5781 17342 243943 731820 0 0 RICHARD MAGNUSON TREASURER/CFO 117923 353770 71036 213107 19684 59052 25140 75419 2492 7475 236275 708823 0 0 WAEL FAKHRY ASSISTANT TREASURER/SVP FINOPS 63376 236984 21799 81516 692 2586 6913 25849 6080 22733 98860 369668 0 0 DAVID HORNE CHAIRPERSON/PROFESSOR 368776 0 205994 0 65113 0 20952 0 25963 0 686798 0 0 0 LARRY A COUTURE SVP CATD 311402 0 105470 0 15824 0 20952 0 19726 0 473374 0 0 0 ASHLEY BAKER LEE SVP, RESEARCH OPERATIONS 300467 0 141557 0 3267 0 30443 0 28174 0 503908 0 0 0 GERD PFEIFER CHAIRPERSON/PROFESSOR 296300 0 11716 0 1290 0 38250 0 17147 0 364703 0 0 0 HUA YU JOVE PROFESSOR 273865 0 9888 0 164292 0 38250 0 10515 0 496810 0 0 0 LESLIE BERNSTEIN DEAN OF FACULTY AFFAIRS 341180 0 10165 0 3040 0 38250 0 13446 0 406081 0 0 0 RAMA NATARAJAN CHAIRPERSON/PROFESSOR 270496 0 20490 0 1766 0 38250 0 12171 0 343173 0 0 0 RICHARD JOVE FORMER OFFICER 212041 0 0 0 46623 0 32308 0 10243 0 301215 0 0 0 VALERIE BINGHAM FORMER OFFICER,VP/CONTROLLER 56102 168306 13368 40102 1638 4915 4640 13918 6601 19804 82349 247045 0 0 RICHARD THOMPSON VP, FACILITIES 75090 225269 16990 50969 3706 11117 5238 15714 2182 6545 103206 309614 0 0 DEBRA FIELDS CHIEF RISK OFFICER 83261 249784 55630 166888 4046 12137 16023 48069 8395 25184 167355 502062 0 0 PAUL CONOCENTI SVP AND CIO 94950 284848 34871 104611 37079 111236 9303 27909 8185 24555 184388 553159 0 0 STEPHANIE NEUVIRTH CHIEF HR OFFICER 110612 331835 60940 182819 802 2405 24852 74555 7603 22810 204809 614424 0 0 QUESTIONS REGARDING COMPENSATION: SCHEDULE J, PART I, LINE 1A HUA YU WAS PROVIDED TAX GROSS UP ASSISTANCE, IN THE FORM OF A BONUS, ASSOCIATED WITH THE AMORTIZATION OF A MORTGAGE ASSISTANCE LOAN. BOTH THE AMORTIZATION OF THE MORTGAGE ASSISTANCE AND THE TAX GROSS UP ASSISTANCE ARE INCLUDED IN HUA YU'S TAXABLE INCOME IN SCHEDULE J, PART II, COLUMN B(III). SCHEDULE J, PART I, LINE 3 THE CHIEF EXECUTIVE OFFICER OF THE ORGANIZATION IS NOT COMPENSATED BY THE BECKMAN RESEARCH INSTITUTE BUT BY THE MEDICAL CENTER. CHIEF EXECUTIVE OFFICER COMPENSATION IS ESTABLISHED BY THE EXECUTIVE COMPENSATION AND GOVERNANCE COMMITTEE OF THE CITY OF HOPE BOARD OF DIRECTORS. ALL SOURCES INDICATED IN LINE 3 ARE UTILIZED BY THIS COMMITTEE TO SET SUCH COMPENSATION. SEE NARRATIVE FOR SCHEDULE O, PART VI, LINE 15A. SCHEDULE J, PART I, LINE 4B THE BECKMAN RESEARCH INSTITUTE HAS AN EXECUTIVE SUPPLEMENTAL ACCUMULATION PLAN THAT IS A NON-QUALIFIED SECTION 457(F) PLAN. THE PLAN IS DESIGNED AND MAINTAINED TO PROVIDE A SELECT GROUP OF MANAGEMENT OR HIGHLY COMPENSATED EMPLOYEES WITH DEFERRED COMPENSATION. THE PLAN VESTS AFTER THREE (3) FISCAL YEARS OF SERVICE AND THE VESTED TOTALS ARE INCLUDED IN SCHEDULE J, PART II, COLUMN B(III). PRIOR TO VESTING THE ANNUAL AMOUNTS ARE INCLUDED IN SCHEDULE J, PART II, COLUMN C. PURSUANT TO THE PLAN DOCUMENT, VESTED PARTICIPANTS ARE ENTITLED TO WITHDRAW FROM THEIR VESTED ACCOUNT AN AMOUNT EQUAL TO THE FEDERAL, STATE, LOCAL, AND FICA TAXES. THESE AMOUNTS ARE REMITTED TO THE APPROPRIATE TAXING AUTHORITIES ON BEHALF OF THE PARTICIPANTS. DURING CALENDAR YEAR 2013 THE FOLLOWING INDIVIDUALS WITHDREW THE REFERENCED AMOUNTS TO COVER SUCH TAXES: VALERIE BINGHAM $ 1,352 MICHAEL FRIEDMAN $26,500 DAVID HORNE $ 4,263 GREGORY SCHETINA $ 4,839 ROBERT STONE $13,257 DEBRA FIELDS $ 4,260 THESE AMOUNTS HAVE BEEN INCLUDED IN THE PARTICIPANTS' INCOME ON SCHEDULE J, PART II, COLUMN B(III). RICHARD JOVE TERMINATED EMPLOYMENT WITH CITY OF HOPE DURING THE CALENDAR YEAR ENDING DECEMBER 31, 2013 AND RECEIVED DISTRIBUTIONS FROM THE PLAN TOTALING $76,199, WHICH HAS BEEN REPORTED AS TAXABLE COMPENSATION IN EITHER THE CURRENT YEAR OR IN A PRIOR YEAR 990 IN SCHEDULE J, PART II, COLUMN B(III). SCHEDULE J, PART I, LINE 7 THE BECKMAN RESEARCH INSTITUTE EXECUTIVES AND SOME KEY EMPLOYEES ARE ELIGIBLE TO RECEIVE INCENTIVE COMPENSATION TIED TO FIVE (5) KEY INDICATORS AND ONE OR MORE INDIVIDUAL OBJECTIVES. THE KEY INDICATORS ARE BOTH FINANCIAL AND NON-FINANCIAL AND REFLECT KEY AREAS OF STRATEGIC FOCUS, INCLUDING THE EXEMPT HEALTHCARE MISSION OF THE CITY OF HOPE AND AFFILIATES. THE POTENTIAL INCENTIVE COMPENSATION IS BASED ON A WEIGHTED AVERAGE AMONG ALL INDICATORS AND IS PAID AS A PERCENTAGE OF EACH INDIVIDUAL PARTICIPANT'S BASE COMPENSATION. THE KEY INDICATORS ARE WEIGHTED AT 66 2/3%, WHILE THE INDIVIDUAL OBJECTIVES ARE WEIGHTED AT 33 1/3%. BASED UPON AN INDIVIDUAL'S GOALS AND PERFORMANCE DURING THE YEAR, THE POTENTIAL PAYOUT FOR ANY PARTICIPANT CAN BE MODIFIED UP OR DOWN BY AS MUCH AS 20%. THE INCENTIVE PLAN IS UNDER THE CONTROL OF AND ADMINISTERED BY THE INDEPENDENT DIRECTORS SERVING ON THE EXECUTIVE COMPENSATION AND GOVERNANCE COMMITTEE. CITY OF HOPE MAY IN ITS DISCRETION CANCEL ALL OR A PORTION OF ANY INCENTIVE PLAN PAYMENT OR AWARD TO ANY PARTICIPANT, WHETHER BEFORE OR FOLLOWING PAYMENT OF SUCH AWARD, SUBJECT TO COMPLIANCE WITH APPLICABLE LAW, UNDER THESE CIRCUMSTANCES: A) AN INCENTIVE PLAN PAYMENT OR AWARD IS MADE FOR A FISCAL PERIOD AND CITY OF HOPE SUBSEQUENTLY RESTATES OR OTHERWISE ADJUSTS THE ANNUAL PERFORMANCE MEASUREMENT CALCULATIONS IN A MANNER THAT WOULD REDUCE THE SIZE OF THE AWARD OR PAYMENT, OR; B) AN INCENTIVE PLAN PAYMENT OR AWARD IS MADE FOR A FISCAL PERIOD AND CITY OF HOPE SUBSEQUENTLY DETERMINES THAT ONE OR MORE OF THE ANNUAL PERFORMANCE MEASUREMENT CALCULATIONS ON WHICH THE AWARD IS BASED OR IS PAID ARE MATERIALLY INACCURATE. DURING CALENDAR YEAR 2013 CITY OF HOPE PAID THE INCENTIVE COMPENSATION EARNED FOR FISCAL YEAR 2013 AND THIS HAS BEEN REPORTED IN SCHEDULE J, PART II, COLUMN B(II). THE BECKMAN RESEARCH INSTITUTE HAS AN EXECUTIVE LONG TERM INCENTIVE PLAN (LTI) THAT IS DESIGNED TO PROVIDE A LONG TERM INCENTIVE FOR EXECUTIVES OF THE CITY OF HOPE AND AFFILIATES. IN ORDER TO ACCOMPLISH AND REALIZE KEY ORGANIZATIONAL OBJECTIVES AND GOALS OVER THE NEXT TEN YEAR PERIOD, IT IS CRITICAL THAT KEY EXECUTIVES BE ALIGNED WITH THE STRATEGIC PLAN. THE INITIAL PERFORMANCE PERIOD OF THE PLAN (CYCLE 1) RUNS FROM OCTOBER 1, 2012 THROUGH SEPTEMBER 30, 2015, WITH A NEW THREE YEAR PERFORMANCE PERIOD BEGINNING EACH OCTOBER 1 THEREAFTER (E.G., CYCLE 2 RUNS FROM OCTOBER 1, 2013 THROUGH SEPTEMBER 30, 2016). THE PARTICIPANTS MUST BE EMPLOYED BY THE BECKMAN RESEARCH INSTITUTE AT THE END OF THE PERFORMANCE PERIOD IN ORDER TO VEST IN THE PLAN. WHILE THE LTI DOES MEET THE REQUIREMENTS FOR A SUBSTANTIAL RISK OF FORFEITURE, AS OF THE CALENDAR YEAR ENDING DECEMBER 30, 2013, TWELVE MONTHS OF YEAR TWO OF PLAN CYCLE 1 AND THREE MONTHS OF YEAR ONE OF PLAN CYCLE 2 OF THE POTENTIAL LTI AMOUNTS HAVE BEEN ESTIMATED AND ACCRUED DURING THE CURRENT TAX YEAR, AND IS REPORTED AS DEFERRED COMPENSATION IN SCHEDULE J, PART II, COLUMN C. SCHEDULE J, PART II JOHN J. ROSSI, PHD, AND LINDA MALKAS, PHD, ARE MEMBERS OF THE BOARD OF DIRECTORS OF THE BECKMAN RESEARCH INSTITUTE AND ARE ALSO EMPLOYEES OF AND COMPENSATED BY THE BECKMAN RESEARCH INSTITUTE. DR. ROSSI IS A RESEARCH SCIENTIST AND DIRECTOR OF MOLECULAR MEDICINE AND THE DEAN OF THE CITY OF HOPE'S IRELL AND MANELLA GRADUATE SCHOOL OF BIOLOGICAL SCIENCES. DR. MALKAS IS A PROFESSOR AND DEPUTY DIRECTOR FOR BASIC RESEARCH FOR THE CANCER CENTER. NEITHER DR. ROSSI NOR DR. MALKAS ARE COMPENSATED FOR THEIR SERVICES AS A MEMBER OF THE BECKMAN RESEARCH INSTITUTE'S BOARD OF DIRECTORS. EMPLOYEE COMPENSATION FOR BOTH OF THESE INDIVIDUALS IS LISTED ON SCHEDULE J, PART II AND FORM 990, PART VII, SECTION A. A CALIF HLTH FACLTY FIN AUTH (SEE PART VI) 521643828 13033ln37 2012-11-14 57928340 REFUNDING ISSUE/CAPITAL PROJECTS false false false A 0 0 57928742 0 0 0 534551 0 0 9853233 47540958 0 2014 true false false true A false false true true true true 0.01100 0.01100 false false false true A false true true true UNION BKWELLS FARGO 30. false false false 0 false true A true TAX EXEMPT BONDS: SCHEDULE K, PART I, LINE A AN ELECTION WAS MADE UNDER 1.150-1(C)(3) TO TREAT THE BOND ISSUE AS TWO SEPARATE ISSUES AND WAS REPORTED ON TWO SEPARATE FORMS 8038. ONE WAS FOR REFUNDING THE CITY OF HOPE NATIONAL MEDICAL CENTER'S CITY OF DUARTE CERTIFICATES OF PARTICIPATION SERIES 1999A AND THE OTHER WAS FOR REFUNDING (1) THE CITY OF HOPE NATIONAL MEDICAL CENTER PROJECT SERIES 2006A,B,C ISSUES AND (2) THE BECKMAN RESEARCH INSTITUTE'S 2007 CALIFORNIA ENTERPRISE DEVELOPMENT AUTHORITY ISSUE. THIS SECOND FORM 8038 REPORTED AN ISSUE PRICE OF $198,734,018. FOR PURPOSES OF SCHEDULE K REPORTING, THE BECKMAN RESEARCH INSTITUTE IS REPORTING AN ALLOCABLE AMOUNT OF THE ISSUE PRICE AND EXPENDITURES. BECKMAN RESEARCH INSTITUTE IS REPORTING AN ISSUE PRICE OF $57,928,340, WHILE THE CITY OF HOPE NATIONAL MEDICAL CENTER IS REPORTING AN ISSUE PRICE OF $140,805,678. SCHEDULE K, PART I, LINE A COLUMN (F) THE 2012 ISSUE REFUNDED THE FOLLOWING BECKMAN RESEARCH INSTITUTE TAX EXEMPT ISSUE: PRIVATE PLACEMENT ISSUED ON JULY 12, 2007 THROUGH CALIFORNIA ENTERPRISE DEVELOPMENT AUTHORITY. Linda Malkas DIRECTOR Mtg Subsidy X 500000 460610 false true true 460610 KIRSTEN ROOD SPOUSE OF A KEY EMPLOYEE 83819 EMPLOYEE COMPENSATION false SYLVANA COUTURE SPOUSE OF A KEY EMPLOYEE 84064 EMPLOYEE COMPENSATION false ROBERT HICKEY SPOUSE OF A DIRECTOR 169522 EMPLOYEE COMPENSATION false HUA YU SPOUSE OF FORMER OFFICER 540398 EMPLOYEE COMPENSATION false LOANS TO/FROM INTERESTED PERSONS: SCHEDULE L, PART II LINDA H. MALKAS, PHD, WAS PROVIDED A MORTGAGE ASSISTANCE LOAN AS PART OF HER RECRUITMENT BY THE BECKMAN RESEARCH INSTITUTE. DR. MALKAS MAKES MONTHLY PRINCIPAL AND INTEREST PAYMENTS ON THIS LOAN AND IS CURRENT WITH ALL PAYMENTS. THE LOAN BEARS INTEREST AT 2.42 PERCENT PER ANNUM AND IS SECURED BY REAL PROPERTY IN THE STATE OF CALIFORNIA. THE NOTE IS DUE IN FULL FOR ANY REMAINING OUTSTANDING PRINCIPAL AND INTEREST THE EARLIER OF MAY 9, 2021 OR THE TERMINATION OF DR. MALKAS' EMPLOYMENT. ORGANIZATION'S MISSION: FORM 990, PART III LINE 1 ORGANIZATION'S MISSION CITY OF HOPE (COLLECTIVELY REFERRING TO CITY OF HOPE, THE MEDICAL CENTER, THE MEDICAL FOUNDATION, BECKMAN RESEARCH INSTITUTE, AND CITY OF HOPE AUXILIARIES) IS AN INNOVATIVE BIOMEDICAL RESEARCH, TREATMENT AND EDUCATIONAL INSTITUTION COMMITTED TO TRANSFORMING THE FUTURE OF HEALTH. EVERY DAY WE TURN SCIENCE INTO PRACTICAL BENEFIT. WE TURN HOPE INTO REALITY. WE ACCOMPLISH THIS THROUGH EXQUISITE CARE, INNOVATIVE RESEARCH, AND VITAL EDUCATION FOCUSED ON ELIMINATING CANCER, DIABETES AND OTHER LIFE-THREATENING DISEASES. CITY OF HOPE IS GUIDED BY A COMPASSIONATE, PATIENT-CENTERED PHILOSOPHY AND SUPPORTED BY A NATIONAL FOUNDATION OF HUMANITARIAN PHILANTHROPY. PROGRAM SERVICE ACCOMPLISHMENTS: FORM 990, PART III, LINE 4A BECKMAN RESEARCH INSTITUTE HAS PIONEERED SCIENTIFIC BREAKTHROUGHS RESULTING IN TREATMENTS THAT HAVE IMPROVED THE LIVES OF PATIENTS WORLDWIDE. NUMEROUS LIFE-SAVING DRUGS USE PATENTED TECHNOLOGY DEVELOPED AT BECKMAN RESEARCH INSTITUTE; THESE DRUGS INCLUDE SYNTHETIC HUMAN INSULIN (HUMULIN) FOR DIABETES, THE WIDELY USED CANCER DRUGS HERCEPTIN, RITUXAN AND AVASTIN, AND HUMIRA FOR ARTHRITIS. BECKMAN RESEARCH INSTITUTE'S MISSION IS TO SUPPORT INNOVATIVE AND CREATIVE RESEARCH AND TO EDUCATE FUTURE SCIENTISTS IN THE BIOLOGICAL SCIENCES. RESEARCH IS OF THE HIGHEST CALIBER AND DIRECTED TO AN UNDERSTANDING OF THE MOLECULES AND PROCESSES OF LIFE, INCLUDING THOSE PROCESSES IMPORTANT TO THE CAUSES, PREVENTION AND CURE OF HUMAN DISEASE. RESEARCHERS AT BECKMAN RESEARCH INSTITUTE UNDERTAKE FUNDAMENTAL INVESTIGATIONS IN MOLECULAR GENETICS AND CELLULAR BIOLOGY, STUDYING BIOLOGICAL PROCESSES, CELL DIFFERENTIATION AND EARLY DEVELOPMENT, CELLULAR SIGNALING, RNA PROCESSING AND GENOMIC STRUCTURE. THEY HAVE ACHIEVED MAJOR ADVANCES IN RECOMBINANT DNA TECHNOLOGY, MONOCLONAL ANTIBODIES, GENE THERAPY, EPIGENETICS, SI-RNA TECHNOLOGY AND CANCER IMMUNOTHERAPEUTICS. A DEPARTMENT IN BECKMAN RESEARCH INSTITUTE IS DEDICATED TO UNDERSTANDING AND DEVELOPING TREATMENTS BASED ON CANCER'S INTERACTION WITH THE IMMUNE SYSTEM. OTHER RESEARCH HAS IDENTIFIED PROTEINS THAT MAY PLAY CRITICAL ROLES IN IMMUNE RESPONSE AND MAY LEAD TO NEW TREATMENT STRATEGIES. ANOTHER MAJOR EMPHASIS FOR THE BECKMAN RESEARCH INSTITUTE SCIENTISTS IS PERSONALIZED RESEARCH AND MEDICINE - ANALYZING PATIENTS' UNIQUE GENETIC PROFILEs TO DEVELOP TAILORED THERAPIES for THEIR SPECIFIC DISEASE. ALL OF THIS RESEARCH IS UNIQUELY SUPPORTED BY ONSITE MANUFACTURING FACILITIES THAT CAN TEST AND PRODUCE QUANTITIES OF CELL-BASED, GENE-BASED AND MOLECULAR THERAPIES. THESE FACILITIES FURTHER SERVE AS RESOURCES TO MEDICAL AND RESEARCH CENTERS NATIONWIDE. BECKMAN RESEARCH INSTITUTE SCIENTISTS SERVE AS FACULTY MEMBERS IN CITY OF HOPE'S IRELL & MANELLA GRADUATE SCHOOL OF BIOLOGICAL SCIENCES. THE GRADUATE SCHOOL'S MISSION IS TO TRAIN STUDENTS TO BE OUTSTANDING RESEARCH SCIENTISTS IN CHEMICAL, MOLECULAR AND CELLULAR BIOLOGY. THE SCHOOL IS ACCREDITED BY THE WESTERN ASSOCIATION OF SCHOOLS AND COLLEGES. GRADUATES OF THE PROGRAM, AWARDED A DOCTOR OF PHILOSOPHY IN BIOLOGICAL SCIENCES, ARE EQUIPPED TO ADDRESS FUNDAMENTAL QUESTIONS IN LIFE SCIENCES AND BIOMEDICINE FOR CAREERS IN ACADEMIA, INDUSTRY AND GOVERNMENT. SCHOOLS QUESTIONNAIRE: FORM 990, PART IV, QUESTION 13 AND SCHEDULE E THE BECKMAN RESEARCH INSTITUTE IS ENGAGED IN THE CONTINUOUS ACTIVE CONDUCT OF MEDICAL AND SCIENTIFIC RESEARCH. BECKMAN RESEARCH INSTITUTE OPERATES A GRADUATE SCHOOL AND COMPLIES WITH REV. PROC. 75-50 EVEN THOUGH THE OPERATIONS OF THE GRADUATE SCHOOL CONSTITUTES LESS THAN 2% OF THE ORGANIZATION'S TOTAL EXPENSES. DUE TO LIMITATIONS IN THE 990 RETURN SOFTWARE APPLICATION, WE ARE UNABLE TO ACCESS THE SCHEDULE E FOR THESE QUESTIONS. THE FOLLOWING RESPONDS TO THE QUESTIONS IN THE SCHEDULE E SCHOOLS QUESTIONNAIRE: 1. DOES THE ORGANIZATION HAVE A RACIALLY NONDISCRIMINATORY POLICY TOWARD STUDENTS BY STATEMENT IN ITS CHARTER, BYLAWS, OTHER GOVERNING INSTRUMENT, OR IN A RESOLUTION OF ITS GOVERNING BODY? "YES" 2. DOES THE ORGANIZATION INCLUDE A STATEMENT OF ITS RACIALLY NONDISCRIMINATORY POLICY TOWARD STUDENTS IN ALL ITS BROCHURES, CATALOGUES, AND OTHER WRITTEN COMMUNICATIONS WITH THE PUBLIC DEALING WITH STUDENT ADMISSIONS, PROGRAMS, AND SCHOLARSHIPS? "YES" 3. HAS THE ORGANIZATION PUBLICIZED ITS RACIALLY NONDISCRIMINATORY POLICY THROUGH NEWSPAPER OR BROADCAST MEDIA DURING THE PERIOD OF SOLICITATION FOR STUDENTS, OR DURING THE REGISTRATION PERIOD IF IT HAS NO SOLICITATION PROGRAM, IN A WAY THAT MAKES THE POLICY KNOWN TO ALL PARTS OF THE GENERAL COMMUNITY IT SERVES? IF YES, PLEASE DESCRIBE, IF NO, PLEASE EXPLAIN. "NO." THE GRADUATE SCHOOL CUSTOMARILY DRAWS A SUBSTANTIAL PERCENTAGE OF ITS STUDENTS FROM LARGE GEOGRAPHIC SECTIONS OF THE UNITED STATES AND INTERNATIONALLY, AND FOLLOWS A RACIALLY NONDISCRIMINATORY POLICY AS DEMONSTRATED BY ITS CURRENT ENROLLMENT OF STUDENTS OF RACIAL MINORITY GROUPS IN MEANINGFUL NUMBERS. ACCORDINGLY, THE GRADUATE SCHOOL SATISFIES THE PUBLICITY REQUIREMENTS OF SECTION 4.03 BY COMPLYING WITH SECTION 4.02 IN THAT IT INCLUDES A STATEMENT OF ITS RACIALLY NONDISCRIMINATORY POLICY AS TO STUDENTS IN ITS CATALOGUES AND ON THE ORGANIZATION'S WEBSITE. 4. DOES THE ORGANIZATION MAINTAIN THE FOLLOWING: 4A. RECORDS INDICATING THE RACIAL COMPOSITION OF THE STUDENT BODY, FACULTY, AND ADMINISTRATIVE STAFF? "YES" 4B. RECORDS DOCUMENTING THAT SCHOLARSHIPS AND OTHER FINANCIAL ASSISTANCE ARE AWARDED ON A RACIALLY NONDISCRIMINATORY BASIS? "YES" 4C. COPIES OF ALL CATALOGUES, BROCHURES, ANNOUNCEMENTS, AND OTHER WRITTEN COMMUNICATIONS TO THE PUBLIC DEALING WITH STUDENT ADMISSIONS, PROGRAMS, AND SCHOLARSHIPS? "YES" 4D. COPIES OF ALL MATERIAL USED BY THE ORGANIZATION OR ON ITS BEHALF TO SOLICIT CONTRIBUTIONS? "YES" 5. DOES THE ORGANIZATION DISCRIMINATE BY RACE IN ANY WAY WITH RESPECT TO: 5A. STUDENT'S RIGHTS OR PRIVILEGES? "NO" 5B. ADMISSIONS POLICIES? "NO" 5C. EMPLOYMENT OF FACULTY OR ADMINISTRATIVE STAFF? "NO" 5D. SCHOLARSHIPS OR OTHER FINANCIAL ASSISTANCE? "NO" 5E. EDUCATIONAL POLICIES? "NO" 5F. USE OF FACILITIES? "NO" 5G. ATHLETIC PROGRAMS? "NO" 5H. OTHER EXTRACURRICULAR ACTIVITIES? "NO" 6A. DOES THE ORGANIZATION RECEIVE ANY FINANCIAL AID OR ASSISTANCE FROM A GOVERNMENTAL AGENCY? "NO" 6B. HAS THE ORGANIZATION'S RIGHT TO SUCH AID EVER BEEN REVOKED OR SUSPENDED? "NO" 7. DOES THE ORGANIZATION CERTIFY THAT IT HAS COMPLIED WITH THE APPLICABLE REQUIREMENTS OF SECTIONS 4.01 THROUGH 4.05 OF REV. PROC. 75-50, 1975-2 C.B. 587, COVERING RACIAL NONDISCRIMINATION? "YES" ADMISSION TO CITY OF HOPE'S IRELL & MANELLA GRADUATE SCHOOL OF BIOLOGICAL SCIENCES, WHICH ACCEPTS APPLICATIONS ON AN INTERNATIONAL BASIS, IS HIGHLY COMPETITIVE. CANDIDATES ARE EVALUATED ON THE BASIS OF THEIR TEST SCORES, GRADES FROM COLLEGE AND GRADUATE LEVEL COURSEWORK, LETTERS OF RECOMMENDATION, AND ON THE SCHOOL'S ASSESSMENT OF THE CANDIDATES' POTENTIAL TO CONDUCT MEANINGFUL AND SIGNIFICANT BIOLOGICAL, BIOMEDICAL AND/OR CHEMICAL RESEARCH. ALL STUDENTS ADMITTED TO THE GRADUATE SCHOOL RECEIVE A STIPEND. THE AMOUNT OF THE STIPEND IS DETERMINED BASED ON STIPEND LEVELS AT OTHER CALIFORNIA GRADUATE SCHOOLS WITH SIMILAR PROGRAMS AND IS THE SAME FOR ALL STUDENTS IN THE PROGRAM. GOVERNING BODY AND MANAGEMENT: FORM 990, PART VI, SECTION A, LINE 4 AT ITS MEETING ON MAY 16, 2014, THE BOARD OF DIRECTORS OF CITY OF HOPE, THE SOLE CORPORATE MEMBER OF THE MEDICAL CENTER, BECKMAN RESEARCH INSTITUTE AND MEDICAL FOUNDATION, APPROVED REVISIONS TO THE BYLAWS TO RESTORE THE EXECUTIVE LEADERSHIP STRUCTURE AS IT EXISTED BEFORE CHANGES MADE IN 2012. SPECIFICALLY, THE BOARD APPROVED REVISIONS THAT RECOMBINED THE PRESIDENT AND CEO ROLES AND TITLES, AND DISCONTINUED THE OFFICE OF THE CHIEF EXECUTIVE. FORM 990, PART VI, SECTION A, LINE 6 AND 7A THE SOLE CORPORATE MEMBER, CITY OF HOPE (95-3435919), ELECTS THE BOARD OF DIRECTORS TO BECKMAN RESEARCH INSTITUTE. FORM 990, PART VI, SECTION A, LINE 7B CERTAIN ACTIONS MAY NOT BE UNDERTAKEN WITHOUT THE PRIOR WRITTEN APPROVAL OF THE SOLE CORPORATE MEMBER, CITY OF HOPE, AS SPECIFIED IN THE GOVERNING DOCUMENTS OF BECKMAN RESEARCH INSTITUTE, INCLUDING: BORROW MONEY IN THE NAME OF BECKMAN RESEARCH INSTITUTE OR UTILIZING PROPERTY OWNED BY BECKMAN RESEARCH INSTITUTE AS SECURITY FOR SUCH LOANS; ASSIGN, TRANSFER, PLEDGE, COMPROMISE OR RELEASE ANY OF THE CLAIMS OR DEBTS TO BECKMAN RESEARCH INSTITUTE EXCEPT ON PAYMENT IN FULL, OR ARBITRATE OR CONSENT TO THE ARBITRATION OF ANY DISPUTE OR CONTROVERSY OF BECKMAN RESEARCH INSTITUTE; MAKE, EXECUTE OR DELIVER ANY ASSIGNMENT FOR THE BENEFIT OF CREDITORS, OR ANY BOND, CONFESSION OF JUDGMENT, CHATTEL MORTGAGE, SECURITY AGREEMENT, DEED, GUARANTY, INDEMNITY BOND, SURETY BOND, OR CONTRACT TO SELL OR BILL OF SALE OF THE PROPERTY OF BECKMAN RESEARCH INSTITUTE; ACQUIRE, PURCHASE, DEVELOP, IMPROVE, SELL, LEASE, OR MORTGAGE ANY CORPORATE REAL ESTATE OR ANY INTEREST THEREIN OR ENTER INTO ANY CONTRACT FOR ANY SUCH PURPOSES; OR MAKE ANY LOAN, INVESTMENT, TRANSFER OR DISPOSITION OF ANY ASSETS OF BECKMAN RESEARCH INSTITUTE OR ENTER INTO ANY CONTRACT OR INCUR ANY LIABILITIES ON BEHALF OF BECKMAN RESEARCH INSTITUTE OTHER THAN FOR FAIR CONSIDERATION AND IN THE ORDINARY COURSE OF BUSINESS RELATING TO ITS NORMAL DAILY OPERATION; OR ESTABLISH CAPITAL AND OPERATING BUDGETS OR ADOPT MATERIAL CHANGES THERETO; OR ANY ACTION THAT COULD REASONABLY BE EXPECTED TO HAVE A MATERIAL ADVERSE EFFECT ON THE 501(C)(3) STATUS OF TAX-EXEMPT BONDS OF CITY OF HOPE AND AFFILIATES. THE FOLLOWING REQUIRE GOVERNING BODY APPROVAL (AS WELL AS THE APPROVAL OF THE SOLE CORPORATE MEMBER): THE ADOPTION OF, OR MATERIAL CHANGE IN, THE MISSION OF BECKMAN RESEARCH INSTITUTE; SALE OR DISPOSITION OF ALL OR SUBSTANTIALLY ALL ASSETS; MERGER AND ITS PRINCIPAL TERMS (AND ANY AMENDMENT TO THOSE TERMS); DISSOLUTION OF THE CORPORATION; ADOPTION OF OPERATING AND CAPITAL BUDGETS; ACQUISITIONS AND CAPITAL EXPENDITURES MEETING A CERTAIN FINANCIAL THRESHOLD; BORROWINGS, GUARANTIES, LOANS, AND BOND ISSUANCE MEETING A CERTAIN FINANCIAL THRESHOLD; CREATION OF A NEW (OR ACQUISITION OF A CONTROLLING INTEREST IN AN EXISTING) CORPORATION, PARTNERSHIP OR LIMITED LIABILITY COMPANY; AND ADOPTION OF OR AMENDMENTS TO INDIVIDUAL CORPORATE INVESTMENT GUIDELINES. POLICIES: FORM 990, PART VI, SECTION B, LINE 11B A COPY OF THE FORM 990 IS REVIEWED BY THE AUDIT AND COMPLIANCE COMMITTEE OF THE BOARD OF DIRECTORS OF CITY OF HOPE, WHICH ASSISTS THE BECKMAN RESEARCH INSTITUTE'S BOARD IN FULFILLING ITS RESPONSIBILITIES REGARDING THE FINANCIAL, ACCOUNTING, AND CORPORATE COMPLIANCE MATTERS OF BECKMAN RESEARCH INSTITUTE. CITY OF HOPE'S AUDIT AND COMPLIANCE COMMITTEE ALSO SERVES AS THE AUDIT AND COMPLIANCE COMMITTEE OF BECKMAN RESEARCH INSTITUTE. ADDITIONALLY, THE PREPARATION OF THE FORM 990 IS DONE INTERNALLY AND IS REVIEWED THOROUGHLY WITH INTERNAL LEADERSHIP AND EXTERNAL PARTICIPANTS, INCLUDING EY AND RETAINED OUTSIDE TAX COUNSEL. PRIOR TO FILING, THE BECKMAN RESEARCH INSTITUTE FORM 990 IS MADE AVAILABLE TO VOTING MEMBERS OF THE CITY OF HOPE BOARD OF DIRECTORS FOR REVIEW ELECTRONICALLY. FORM 990, PART VI, SECTION B, LINE 12C ALL EMPLOYEES OF CITY OF HOPE AND AFFILIATES, MEMBERS OF THE BOARDS OF DIRECTORS, BOARD COMMITTEE MEMBERS AND RESEARCH TEAM MEMBERS ARE COVERED BY CITY OF HOPE'S APPLICABLE CONFLICT OF INTEREST POLICIES. DETERMINATIONS AS TO WHETHER A CONFLICT OF INTEREST EXISTS AND REVIEW OF SUCH CONFLICT DISCLOSURES ARE MADE BY THE CHIEF RISK OFFICER, GENERAL COUNSEL AND, AS APPLICABLE, THE CHAIR OF THE BOARD OR BOARD OF DIRECTORS OR THE CONFLICT OF INTEREST AND COMMITMENT COMMITTEE, BASED UPON THE CATEGORY OF PERSON MAKING THE DISCLOSURE. RESTRICTIONS IMPOSED ON PERSONS WITH A CONFLICT VARY, BASED UPON THE FACTS AND MAY INCLUDE: PROHIBITION FROM PARTICIPATING IN A GOVERNING BODY'S DELIBERATIONS AND VOTING ON A GIVEN TRANSACTION OR SET OF TRANSACTIONS; RECUSAL FROM THE DECISION-MAKING PROCESS RELATING TO BUSINESS TRANSACTIONS (E.G., PURCHASING DECISIONS); PROHIBITION FROM PARTICIPATING AS A PRINCIPAL INVESTIGATOR IN RESEARCH; AND DISCLOSURE OF FINANCIAL INTEREST IN RESEARCH STUDY INFORMED CONSENT FORMS AND PUBLICATIONS. MONITORING TRANSACTIONS FOR CONFLICTS OF INTEREST IS DONE THROUGH REQUIRED DISCLOSURES AND UPDATES BY PERSONS COVERED BY THE ORGANIZATION'S CONFLICT OF INTEREST POLICIES AND A CONCURRENT REVIEW OF SUCH DISCLOSURES AGAINST TRANSACTIONS. CITY OF HOPE POLICY PROVIDES FOR DISCIPLINARY ACTION AGAINST PERSONS COVERED BY THE CONFLICT OF INTEREST POLICIES WHO DO NOT COMPLY WITH POLICY REQUIREMENTS. SCHEDULE O, FORM 990, PART VI, SECTION B, LINES 15A AND 15B THE EXECUTIVE COMPENSATION AND GOVERNANCE COMMITTEE OF THE BOARD OF DIRECTORS ("COMMITTEE"), PURSUANT TO A DELEGATION OF AUTHORITY FROM THE CITY OF HOPE BOARD OF DIRECTORS, IS RESPONSIBLE FOR SETTING THE COMPENSATION OF THE CEO AND CERTAIN OTHER SENIOR EXECUTIVES. THE DIRECTORS ON THIS COMMITTEE ARE INDEPENDENT AND ADHERE TO A STRICT CONFLICT OF INTEREST POLICY. DELIBERATION AND DECISION MAKING ARE SUBSTANTIATED IN THE MINUTES OF THE COMMITTEE'S MEETINGS. THE MINUTES ARE REVIEWED AND APPROVED AT THE NEXT MEETING OF THE COMMITTEE. AS PART OF THE DELIBERATION PROCESS, THE COMMITTEE RECEIVES ADVICE FROM AN INDEPENDENT, THIRD-PARTY COMPENSATION CONSULTANT WITH RESPECT TO EXECUTIVE COMPENSATION, INCLUDING REVIEW OF COMPARABLE AND OTHER BENCHMARK DATA, CURRENT COMPENSATION PHILOSOPHY, STRUCTURE, AND ADMINISTRATION OF THE EXECUTIVE CASH COMPENSATION PROGRAMS AT CITY OF HOPE AND AFFILIATES. THE COMMITTEE CARRIES OUT THE BOARD OF DIRECTORS' OVERALL RESPONSIBILITIES RELATING TO EXECUTIVE COMPENSATION. THE EXECUTIVE COMPENSATION PHILOSOPHY IS DESIGNED TO ATTRACT AND RETAIN THE CALIBER OF EXECUTIVE LEADERSHIP REQUIRED TO ENABLE CITY OF HOPE TO ACHIEVE THE HIGHEST LEVELS OF COMMUNITY BENEFIT, IMPACT TO CLINICAL CARE, QUALITY RESEARCH AND EFFICIENT PHILANTHROPIC DEVELOPMENT. THE COMMITTEE TARGETS THE 50TH PERCENTILE OF BASE SALARY AND THE 75TH PERCENTILE OF TOTAL CASH OF THE MARKET IN WHICH BECKMAN RESEARCH INSTITUTE COMPETES FOR EXECUTIVES. A SUBSTANTIAL PORTION OF EXECUTIVE COMPENSATION IS LINKED DIRECTLY TO PERFORMANCE GOALS APPROVED IN ADVANCE BY THE COMMITTEE. THESE GOALS ARE TIED TO THE PERFORMANCE OF CITY OF HOPE AND AFFILIATES, INCLUDING THE ATTAINMENT OF SPECIFIC BUSINESS OBJECTIVES FOR STRATEGIC AND FINANCIAL PERFORMANCE AS WELL AS NON-FINANCIAL MEASURES SUCH AS PATIENT SATISFACTION AND QUALITY OF PATIENT CARE. AS A CONSEQUENCE, PERFORMANCE COMPENSATION MAY VARY FROM YEAR TO YEAR. THE COMMITTEE CONDUCTS ANNUAL COMPENSATION REVIEWS FOR EXECUTIVES AND CERTAIN KEY EMPLOYEES AND THIS WAS LAST COMPLETED ON DECEMBER 11, 2014. THE COMPENSATION PROGRAMS AND RANGES FOR ALL OFFICERS AND KEY EMPLOYEES LISTED ON FORM 990, PART VII AT THE SVP OR EQUIVALENT LEVEL AND ABOVE ARE REVIEWED BY THIS COMMITTEE. DISCLOSURES: FORM 990, PART VI, SECTION C, LINE 19 BECKMAN RESEARCH INSTITUTE'S ARTICLES OF INCORPORATION ARE AVAILABLE TO THE PUBLIC FROM THE SECRETARY OF STATE. CITY OF HOPE AND AFFILIATES' AUDITED FINANCIAL STATEMENTS ARE AVAILABLE ON THE CITY OF HOPE WEBSITE, AND ITS CONFLICT OF INTEREST POLICIES ARE AVAILABLE BY WRITTEN REQUEST MADE TO THE CONFLICT OF INTEREST MANAGER. BECKMAN RESEARCH INSTITUTE'S BYLAWS ARE NOT MADE AVAILABLE TO THE PUBLIC. HOURS WORKED: FORM 990, PART VII, COLUMN (B) FULL TIME EXEMPT EMPLOYEES GENERALLY WORK IN EXCESS OF 40 HOURS PER WEEK, WHICH HAS BEEN REFLECTED IN PART VII BY AN ESTIMATE OF 60 HOURS PER WEEK. THE MEMBERS OF THE BOARD OF DIRECTORS ARE NOT COMPENSATED FOR SERVING ON THE BOARD. THE HOURS WORKED FOR EACH DIRECTOR IS AN ESTIMATE OF THE TIME SPENT PREPARING FOR AND ATTENDING MEETINGS OF THE BOARD OF DIRECTORS. THE BOARD OF DIRECTORS HELD THREE REGULARLY SCHEDULED MEETINGS DURING FISCAL YEAR 2014. THE AUDIT AND COMPLIANCE COMMITTEE HELD FIVE REGULARLY SCHEDULED MEETINGS IN FISCAL YEAR 2014. MOST OF THE CITY OF HOPE OFFICERS AND KEY EMPLOYEES, AS WELL AS A FEW OF ITS HIGHEST COMPENSATED EMPLOYEES, PROVIDE SERVICES TO MORE THAN ONE CITY OF HOPE ENTITY, AND MANY OF THEM PROVIDE SERVICES TO ALL OF THE ENTITIES. FOR A NUMBER OF THESE CONCURRENTLY-EMPLOYED INDIVIDUALS, THE ENTITIES HAVE DESIGNATED THE MEDICAL CENTER AS THE "COMMON PAYMASTER," AS THAT IS DEFINED IN SECTION 3121(S) OF THE INTERNAL REVENUE CODE. CITY OF HOPE REPORTS THESE CONCURRENT EMPLOYEES' TIME, EFFORT AND COMPENSATION ON THE INFORMATION RETURNS OF THE CITY OF HOPE ENTITIES BASED ON THE ESTIMATES OF THEIR TIME SPENT IN AND FOR EACH SUCH ENTITY. AS "COMMON PAYMASTER," THE MEDICAL CENTER ISSUES EACH OF THESE EMPLOYEES A SINGLE, COMBINED PAYCHECK AND ONE FORM W-2. RECONCILIATION OF NET ASSETS: FORM 990, PART XI, LINE 9 CHANGE IN FAIR VALUE OF INTEREST RATE SWAP AGREEMENT -$2,050,496 CITY OF HOPE 1500 EAST DUARTE ROAD DUARTE CA 91010 953435919 FUNDRAISING CA 501(C)3 7 NA false CITY OF HOPE NATIONAL MEDICAL CENTER 1500 EAST DUARTE ROAD DUARTE CA 91010 951683875 HOSPITAL CA 501(C)3 3 CITY OF HOPE true City of Hope Medical Foundation 1500 E Duarte Road Duarte CA 91010 274803222 Healthcare CA 501(C)3 3 City of Hope true GENBASIX INCORPORATED 1500 EAST DUARTE ROAD DUARTE CA 91010 911949357 GENOMICS DE NA C CORP Oncology Management Services Inc 1500 East Duarte Road 147 Duarte CA 91010 330557670 LEASING AGENT CA NA C corp false false true false false false false false false false false true true false true true true false false CITY OF HOPE NATIONAL MEDICAL CENTER P 34739550 FMV CITY OF HOPE NATIONAL MEDICAL CENTER Q 11677072 FMV CITY OF HOPE NATIONAL MEDICAL CENTER O 8816367 FMV CITY OF HOPE NATIONAL MEDICAL CENTER M 23914928 FMV CITY OF HOPE NATIONAL MEDICAL CENTER L 338230 FMV CITY OF HOPE MEDICAL FOUNDATION Q 119481 FMV